UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 173

Sortiert nach

Metastatic progression of breast cancer: insights from 50 years of autopsies

The Journal of pathology, 2014-01, Vol.232 (1), p.23-31

2014

Volltextzugriff (PDF)

Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer

Modern pathology, 2017-07, Vol.30 (7), p.952-963

2017

Volltextzugriff (PDF)

Novel highly specific anti‐periostin antibodies uncover the functional importance of the fascilin 1‐1 domain and highlight preferential expression of periostin in aggressive breast cancer

International journal of cancer, 2016-04, Vol.138 (8), p.1959-1970

2016

Volltextzugriff (PDF)

John F. R. Kerr (1934–2024): Apoptosis: a basic biological phenomenon

Cell death and differentiation, 2024-07

2024

Volltextzugriff (PDF)

The power of an idea: Andrew Wyllie

Cell death and differentiation, 2022-09, Vol.29 (9), p.1671-1672

2022

Volltextzugriff (PDF)

Molecular, Pathologic, and Clinical Features of Early-Onset Endometrial Cancer: Identifying Presumptive Lynch Syndrome Patients

Clinical cancer research, 2008-03, Vol.14 (6), p.1692-1700

2008

Volltextzugriff (PDF)

Expression Profiling of Archival Tumors for Long-term Health Studies

Clinical cancer research, 2012-11, Vol.18 (22), p.6136-6146

2012

Volltextzugriff (PDF)

Molecular classification of breast cancer

Virchows Archiv : an international journal of pathology, 2014-07, Vol.465 (1), p.1-14

2014

Volltextzugriff (PDF)

Relationship of the Breast Ductal Carcinoma In Situ Immune Microenvironment with Clinicopathological and Genetic Features

Clinical cancer research, 2017-09, Vol.23 (17), p.5210-5217

2017

Volltextzugriff (PDF)

Pitfalls and controversies in pathology impacting breast cancer management

Expert review of anticancer therapy, 2020-03, Vol.20 (3), p.205-219

2020

Volltextzugriff (PDF)

PI3K Inhibitors Synergize with FGFR Inhibitors to Enhance Antitumor Responses in FGFR2mutant Endometrial Cancers

Molecular cancer therapeutics, 2017-04, Vol.16 (4), p.637-648

2017

Volltextzugriff (PDF)

Mixed ductal‐lobular carcinomas: evidence for progression from ductal to lobular morphology

The Journal of pathology, 2018-04, Vol.244 (4), p.460-468

2018

Volltextzugriff (PDF)

Fibroadenoma and intraduct papilloma—a common pathogenesis?

Virchows Archiv : an international journal of pathology, 2009-09, Vol.455 (3), p.271-275

2009

Volltextzugriff (PDF)

The “Fas counterattack” is not an active mode of tumor immune evasion in colorectal cancer with high-level microsatellite instability

Human pathology, 2008-02, Vol.39 (2), p.243-250

2008

Volltextzugriff (PDF)

Gastric HER2 Testing Study (GaTHER): an evaluation of gastric/gastroesophageal junction cancer testing accuracy in Australia

The American journal of surgical pathology, 2012-04, Vol.36 (4), p.577-582

2012

Volltextzugriff (PDF)

Lynch syndrome and cervical cancer

International journal of cancer, 2015-12, Vol.137 (11), p.2757-2761

2015

Volltextzugriff (PDF)

Evaluating the repair of DNA derived from formalin-fixed paraffin-embedded tissues prior to genomic profiling by SNP-CGH analysis

Laboratory investigation, 2013-06, Vol.93 (6), p.701-710

2013

Volltextzugriff (PDF)

External quality assurance in nongynecologic cytology: The Australasian experience

Cancer cytopathology, 2017-05, Vol.125 (5), p.349-361

2017

Volltextzugriff (PDF)

Breast cancer metastasis to gynaecological organs: a clinico‐pathological and molecular profiling study

The journal of pathology. Clinical research, 2019-01, Vol.5 (1), p.25-39

2019

Volltextzugriff (PDF)

Assessing HER2 amplification in breast cancer: findings from the Australian In Situ Hybridization Program

Breast cancer research and treatment, 2012-07, Vol.134 (2), p.617-624

2012

Volltextzugriff (PDF)

Nuclear PTEN expression and clinicopathologic features in a population‐based series of primary cutaneous melanoma

International journal of cancer, 2002-05, Vol.99 (1), p.63-67

2002

Volltextzugriff (PDF)

Which are more correctly diagnosed: Conventional Papanicolaou smears or Thinprep samples? A comparative study of 9 years of external quality‐assurance testing

Cancer cytopathology, 2015-02, Vol.123 (2), p.108-116

2015

Volltextzugriff (PDF)

Molecular classification of breast cancer: is it time to pack up our microscopes?

Pathology, 2011-01, Vol.43 (1), p.1-8

2011

Volltextzugriff (PDF)

Mice Lacking the Vascular Endothelial Growth Factor-B Gene (Vegfb) Have Smaller Hearts, Dysfunctional Coronary Vasculature, and Impaired Recovery From Cardiac Ischemia

Circulation research, 2000-02, Vol.86 (2), p.e29-e35

2000

Volltextzugriff (PDF)

1 – 25 von 173

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(160)
Mit Volltextzugriff
(158)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Metastatic progression of breast cancer: insights from 50 years of autopsies

Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer

Novel highly specific anti‐periostin antibodies uncover the functional importance of the fascilin 1‐1 domain and highlight preferential expression of periostin in aggressive breast cancer

John F. R. Kerr (1934–2024): Apoptosis: a basic biological phenomenon

The power of an idea: Andrew Wyllie

Molecular, Pathologic, and Clinical Features of Early-Onset Endometrial Cancer: Identifying Presumptive Lynch Syndrome Patients

Expression Profiling of Archival Tumors for Long-term Health Studies

Molecular classification of breast cancer

Relationship of the Breast Ductal Carcinoma In Situ Immune Microenvironment with Clinicopathological and Genetic Features

Pitfalls and controversies in pathology impacting breast cancer management

PI3K Inhibitors Synergize with FGFR Inhibitors to Enhance Antitumor Responses in FGFR2mutant Endometrial Cancers

Mixed ductal‐lobular carcinomas: evidence for progression from ductal to lobular morphology

Fibroadenoma and intraduct papilloma—a common pathogenesis?

The “Fas counterattack” is not an active mode of tumor immune evasion in colorectal cancer with high-level microsatellite instability

Lynch Syndrome―Associated Breast Cancers: Clinicopathologic Characteristics of a Case Series from the Colon Cancer Family Registry

Gastric HER2 Testing Study (GaTHER): an evaluation of gastric/gastroesophageal junction cancer testing accuracy in Australia

Lynch syndrome and cervical cancer

Evaluating the repair of DNA derived from formalin-fixed paraffin-embedded tissues prior to genomic profiling by SNP-CGH analysis

External quality assurance in nongynecologic cytology: The Australasian experience

Breast cancer metastasis to gynaecological organs: a clinico‐pathological and molecular profiling study

Assessing HER2 amplification in breast cancer: findings from the Australian In Situ Hybridization Program

Nuclear PTEN expression and clinicopathologic features in a population‐based series of primary cutaneous melanoma

Which are more correctly diagnosed: Conventional Papanicolaou smears or Thinprep samples? A comparative study of 9 years of external quality‐assurance testing

Molecular classification of breast cancer: is it time to pack up our microscopes?

Mice Lacking the Vascular Endothelial Growth Factor-B Gene (Vegfb) Have Smaller Hearts, Dysfunctional Coronary Vasculature, and Impaired Recovery From Cardiac Ischemia

Suchergebnisse filtern